Skip to main content
YIFAN PHARMACEUTICAL CO.,LTD logo

YIFAN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002019 ISIN · CNE000001K65 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,497 across all filing types
Latest filing 2022-04-12 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 002019

About YIFAN PHARMACEUTICAL CO.,LTD

https://www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and commercialization of innovative biologics, specialty small molecules, and traditional Chinese medicine. The company maintains a diverse product portfolio, notably featuring Ryzneuta (efbemalenograstim alfa), a long-acting recombinant human granulocyte colony-stimulating factor used to treat chemotherapy-induced neutropenia. It is also recognized as a major global supplier of Vitamin B5 (D-calcium pantothenate). Operating with a global perspective, the firm manages integrated R&D and production platforms that adhere to international quality standards. Its core activities span drug discovery, clinical development, and large-scale manufacturing, with a strategic emphasis on therapeutic areas such as oncology, hematology, and dermatology.

Recent filings

Filing Released Lang Actions
关于回购注销2019年限制性股票激励计划部分限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the company's repurchase and cancellation of restricted shares under its 2019 restricted stock incentive plan. It includes specifics about the number of shares repurchased, reasons for repurchase (such as employee departure and unmet performance targets), pricing, approvals by the board and supervisory committee, legal opinions, and the impact on share capital structure. The document is not a financial report, earnings release, or management discussion but rather a formal announcement of a share repurchase and cancellation event related to stock incentives. This fits the category of Transaction in Own Shares (POS), which covers company buybacks or cancellations of its own shares.
2022-04-12 Chinese
关于公司及控股公司向金融机构申请授信额度及公司合并报表范围内担保额度的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's and its subsidiaries' application for credit facilities from financial institutions and the provision of guarantees within the consolidated financial statement scope. It includes specific financial data such as guarantee amounts, asset-liability ratios, net assets, and other financial metrics for various subsidiaries. The document also discusses board resolutions and shareholder meeting approvals related to these guarantees. The content is focused on capital structure and financing activities, specifically about credit limits and guarantees, rather than a full financial report or earnings release. It is not a report publication announcement since it contains substantive financial and operational details. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2022-04-12 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the company's supervisory board meeting, detailing approvals of various reports including the 2021 annual report, internal control report, audit firm appointment, and other governance matters. It includes voting results and mentions that some items will be submitted to the 2021 annual general meeting for approval. The document is relatively short (2786 characters) and primarily serves as an announcement of meeting resolutions rather than the full annual report or detailed financial statements. It also includes information about supervisory board member candidates and meeting procedural rules. This fits best with the category of Regulatory Filings (RNS), as it is a formal regulatory announcement of meeting resolutions and approvals, not the full annual report or audit report itself.
2022-04-12 Chinese
高级管理人员薪酬管理制度（2022年4月修订）
Remuneration Information Classification · 95% confidence The document is titled '高级管理人员薪酬管理制度' which translates to 'Senior Management Compensation Management System'. It details the policies, principles, and procedures for determining and managing the compensation of senior executives, including the president, vice presidents, board secretary, and CFO. The content includes salary structure, performance assessment, reward mechanisms, and governance related to executive pay. There are no financial statements, audit opinions, or regulatory filings. It is not an announcement or a report of voting results, nor a call transcript or earnings release. It is a detailed governance document related to remuneration policies for senior management, fitting the category of Remuneration Information (DEF 14A). The document length is 4200 characters, which is sufficient for a substantive policy document rather than a brief announcement.
2022-04-12 Chinese
独立董事工作制度（2022年4月修订）
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the rules, conditions, duties, and rights of independent directors within the company, including their appointment, responsibilities, and governance roles. The content is focused on governance practices and internal rules related to the board of directors, specifically independent directors. There is no indication of financial statements, audit results, earnings data, or shareholder meeting materials. The document is a governance-related policy or internal regulation rather than a report or announcement of financial results or corporate actions. Therefore, the most appropriate classification is Governance Information (CGR). The document length (11625 characters) supports it being a full policy document rather than a brief announcement.
2022-04-12 Chinese
股东大会议事规则（2022年4月修订）
Governance Information Classification · 95% confidence The document is titled '股东大会议事规则' which translates to 'Rules of Procedure for the Shareholders' General Meeting'. It details the procedures, rules, and regulations governing the convening, proposal submission, notification, conduct, and supervision of shareholders' meetings. It references legal frameworks such as the Company Law, Securities Law, and stock exchange rules, and includes chapters on general provisions, convening meetings, proposals and notifications, meeting conduct, regulatory measures, and appendices. The content is focused on governance and procedural rules for shareholder meetings rather than reporting financial results or announcements. This matches the description of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices. The document is lengthy (8648 characters) and contains detailed governance rules, not a brief announcement or a report publication notice. Therefore, the appropriate classification is CGR with high confidence.
2022-04-12 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.